BBP vs. PJP
BBP (Virtus LifeSci Biotech Products ETF) and PJP (Invesco Dynamic Pharmaceuticals ETF) are both Health & Biotech Equities funds - BBP tracks the LifeSci Biotechnology Products Index while PJP tracks the Dynamic Pharmaceuticals Intellidex Index. Both are passively managed. Over the past 10 years, BBP returned 13.69%/yr vs 7.44%/yr for PJP. A 0.75 correlation means they provide meaningful diversification when combined. BBP charges 0.79%/yr vs 0.58%/yr for PJP.
Performance
BBP vs. PJP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBP achieves a 16.04% return, which is significantly higher than PJP's 9.74% return. Over the past 10 years, BBP has outperformed PJP with an annualized return of 13.69%, while PJP has yielded a comparatively lower 7.44% annualized return.
BBP
- 1D
- 1.20%
- 1M
- 7.69%
- YTD
- 16.04%
- 6M
- 14.38%
- 1Y
- 59.95%
- 3Y*
- 20.40%
- 5Y*
- 11.34%
- 10Y*
- 13.69%
PJP
- 1D
- 1.74%
- 1M
- 4.87%
- YTD
- 9.74%
- 6M
- 7.29%
- 1Y
- 44.65%
- 3Y*
- 15.79%
- 5Y*
- 8.32%
- 10Y*
- 7.44%
BBP vs. PJP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 16.04% | 33.15% | 3.32% | 17.88% | 0.85% | -8.17% | 22.24% | 24.73% | -13.95% | 24.07% |
PJP Invesco Dynamic Pharmaceuticals ETF | 9.74% | 27.98% | 9.63% | -2.18% | -2.16% | 14.58% | 11.29% | 4.64% | -1.78% | 15.30% |
Correlation
The correlation between BBP and PJP is 0.72, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.72 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.72 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.73 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.74 |
Correlation (All Time) Calculated using the full available price history since Dec 17, 2014 | 0.75 |
The correlation between BBP and PJP has been stable across timeframes, ranging from 0.72 to 0.75 - a consistent structural relationship.
BBP vs. PJP - Sectors Allocation Comparison
Sectors
BBP
PJP
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BBP
PJP
Basic Materials
BBP
-
PJP
-
Communication Services
BBP
-
PJP
-
Consumer Cyclical
BBP
-
PJP
-
Consumer Defensive
BBP
-
PJP
-
Energy
BBP
-
PJP
-
Financial Services
BBP
-
PJP
Industrials
BBP
-
PJP
-
Real Estate
BBP
-
PJP
-
Technology
BBP
-
PJP
-
Utilities
BBP
-
PJP
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBP vs. PJP — Risk / Return Rank
BBP
PJP
BBP vs. PJP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Invesco Dynamic Pharmaceuticals ETF (PJP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBP | PJP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.19 | ||
| Sortino ratioReturn per unit of downside risk | -0.37 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.45 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 6.49 | 4.75 | +1.74 |
| Martin ratioReturn relative to average drawdown | 20.18 | 15.06 | +5.12 |
Loading charts...
Drawdowns
BBP vs. PJP - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, which is greater than PJP's maximum drawdown of -37.06%. Use the drawdown chart below to compare losses from any high point for BBP and PJP.
Loading charts...
Drawdown Indicators
| BBP | PJP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -37.06% | -7.26% |
Max Drawdown (1Y)Largest decline over 1 year | -9.28% | -9.44% | +0.16% |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | -16.27% | -9.82% |
Max Drawdown (5Y)Largest decline over 5 years | -37.89% | -17.51% | -20.38% |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | -33.95% | -10.37% |
Current DrawdownCurrent decline from peak | 0.00% | 0.00% | 0.00% |
Average DrawdownAverage peak-to-trough decline | -11.98% | -8.83% | -3.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.98% | 2.97% | +0.01% |
Volatility
BBP vs. PJP - Volatility Comparison
Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 6.46% compared to Invesco Dynamic Pharmaceuticals ETF (PJP) at 5.39%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than PJP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBP | PJP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.46% | 5.39% | +1.07% |
Volatility (6M)Calculated over the trailing 6-month period | 18.88% | 12.46% | +6.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.96% | 16.58% | +7.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.37% | 16.20% | +10.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.39% | 18.37% | +9.02% |
BBP vs. PJP - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is higher than PJP's 0.58% expense ratio.
Dividends
BBP vs. PJP - Dividend Comparison
BBP has not paid dividends to shareholders, while PJP's dividend yield for the trailing twelve months is around 0.93%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
PJP Invesco Dynamic Pharmaceuticals ETF | 0.93% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
Frequently Asked Questions
BBP and PJP have a correlation of 0.72, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBP has higher volatility (6.46%) compared to PJP (5.39%). In terms of maximum drawdown, BBP dropped -44.32% vs PJP's -37.06%.
On 10-year performance, BBP leads with 13.69% vs 7.44% for PJP. On fees, PJP is cheaper at 0.58% per year. On volatility, PJP has been the lower-risk option at 5.39%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, BBP has performed better with a 13.69% return vs 7.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PJP is cheaper with a 0.58% expense ratio, compared with 0.79% for BBP.
PJP has the higher dividend yield at 0.93%, compared with 0.00% for BBP.
BBP tracks LifeSci Biotechnology Products Index, while PJP tracks Dynamic Pharmaceuticals Intellidex Index. They also come from different issuers: Virtus Investment Partners and Invesco. Their fees differ too: 0.79% for BBP and 0.58% for PJP.
PJP currently has the higher Sharpe Ratio (2.71 vs 2.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBP and PJP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer